Definium Therapeutics, Inc. (DFTX)
23.48
-0.04
(-0.15%)
USD |
NASDAQ |
May 28, 16:00
23.45
-0.04
(-0.15%)
After-Hours: 19:07
Definium Therapeutics Shareholders Equity (Quarterly) : 278.85M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Atai Beckley, Inc. | 198.68M |
| Resonate Blends, Inc. | -4.531M |
| Nutriband, Inc. | 6.680M |
| Q/C Technologies, Inc. | 23.69M |
| GH Research Plc | 263.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 401.29M |
| Total Liabilities (Quarterly) | 122.44M |
| Debt to Equity Ratio | 0.1462 |
| Current Ratio | 4.692 |
| Net Debt Paydown Yield | -0.19% |